Abstract
Registration of many clinical trials seems increasingly likely to become mandatory. Proactive participation by the pharmaceutical industry in the establishment of an authoritative clinical trial registry could have benefits for all stakeholders in clinical research.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
